| scholarly article | Q13442814 |
| P50 | author | Min-Yue Dong | Q87735231 |
| P2093 | author name string | Hui Zhu | |
| Liya Wang | |||
| Min Chen | |||
| Bei Liu | |||
| Kai Yan | |||
| Yu Lei | |||
| Yanmei Yang | |||
| Jianyun Xu | |||
| Junjie Hu | |||
| Yingzhi Huang | |||
| Yeqing Qian | |||
| Hongge Li | |||
| Yixi Sun | |||
| Yuqin Luo | |||
| P2860 | cites work | DNA Sequencing versus Standard Prenatal Aneuploidy Screening | Q22250872 |
| Non-Invasive Prenatal Testing Using Cell Free DNA in Maternal Plasma: Recent Developments and Future Prospects | Q26827338 | ||
| Non-invasive prenatal testing: a review of international implementation and challenges | Q26999426 | ||
| Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center | Q27007785 | ||
| Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays | Q28263829 | ||
| Noninvasive prenatal testing goes global | Q33957923 | ||
| Fetal DNA in maternal plasma: biology and diagnostic applications | Q34098822 | ||
| Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study | Q34482155 | ||
| Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies | Q34496747 | ||
| Coming of age: ten years of next-generation sequencing technologies | Q34526801 | ||
| Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing | Q35032051 | ||
| Appropriate use of estrogen replacement therapy in adolescents and young adults with Turner syndrome and hypopituitarism in light of the Women's Health Initiative | Q36492646 | ||
| Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma | Q37010246 | ||
| An Optimized Method for Accurate Fetal Sex Prediction and Sex Chromosome Aneuploidy Detection in Non-Invasive Prenatal Testing | Q37115493 | ||
| What parents are told after prenatal diagnosis of a sex chromosome abnormality: interview and questionnaire study | Q37129486 | ||
| Noninvasive prenatal screening for fetal common sex chromosome aneuploidies from maternal blood | Q38867682 | ||
| Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. | Q39024055 | ||
| cPAS-based sequencing on the BGISEQ-500 to explore small non-coding RNAs | Q39147050 | ||
| Digital PCR analysis of maternal plasma for noninvasive detection of sickle cell anemia | Q40028010 | ||
| Sex chromosome aneuploidy and aging | Q40416479 | ||
| The potential impact of NIPT as a second-tier screen on the outcomes of high-risk pregnancies with rare chromosomal abnormalities | Q40629052 | ||
| Fetal sex chromosome testing by maternal plasma DNA sequencing: clinical laboratory experience and biology | Q41609597 | ||
| Discordant noninvasive prenatal testing and cytogenetic results: a study of 109 consecutive cases. | Q43981389 | ||
| Non-invasive fetal sex determination by maternal plasma sequencing and application in X-linked disorder counseling | Q44377059 | ||
| Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA. | Q45026733 | ||
| Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma | Q46170290 | ||
| Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors | Q46446186 | ||
| Cell-free DNA analysis for noninvasive examination of trisomy | Q46784231 | ||
| Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing. | Q46892061 | ||
| Noninvasive prenatal testing: limitations and unanswered questions | Q47622449 | ||
| Germline and somatic variant identification using BGISEQ-500 and HiSeq X Ten whole genome sequencing. | Q47661008 | ||
| Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. | Q51767524 | ||
| The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. | Q54708648 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Detection of fetal sex chromosome aneuploidy by massively parallel sequencing of maternal plasma DNA: initial experience in a Chinese hospital | Q57177380 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | molecular biology | Q7202 |
| molecular medicine | Q3523816 | ||
| P304 | page(s) | 59 | |
| P577 | publication date | 2018-12-03 | |
| P1433 | published in | Molecular Cytogenetics | Q15761790 |
| P1476 | title | The application of NIPT using combinatorial probe-anchor synthesis to identify sex chromosomal aneuploidies (SCAs) in a cohort of 570 pregnancies | |
| P478 | volume | 11 |
| Q90447136 | Cell-free DNA screening for sex chromosome aneuploidies by non-invasive prenatal testing in maternal plasma | cites work | P2860 |
Search more.